GORE® EXCLUDER® Devices for Abdominal Aortic Aneurysm

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

Recruiting Observational Study
AAA - Abdominal Aortic Aneurysm
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
2,000 (estimated)
Sponsor
W.L.Gore & Associates · Industry
Who this trial is looking for

This trial is looking for patients who have been treated or are going to be treated with specific GORE® devices for abdominal aortic aneurysm. Participants will have their outcomes tracked for 10 years after the procedure.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years or older.
  • I have provided written consent to join the trial.
  • I have been treated or will be treated with an eligible GORE® device.

You may not be able to join if

  • I am unlikely to attend follow-up visits as required.
  • I am currently enrolled in or plan to enroll in another study within 12 months.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

A prospective, observational post-market registry collecting outcomes through a 10-year post procedure follow-up for patients treated with the GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC Device) or the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE Device) as a part of routine clinical practice.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements 2. Patient has been or is intended to be treated with an eligible registry device 3. Patient is age ≥ 18 years at time of informed co…
Contacts

Karen Martin

928-864-2223

kgmartin@wlgore.com

CONTACT

A. Lekuti

928-864-3576

alekuti@wlgore.com

CONTACT